Australian Broker Call
Produced and copyrighted by at www.fnarena.com
June 06, 2019
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
DCN - | DACIAN GOLD | Downgrade to Neutral from Buy | Citi |
STO - | SANTOS | Upgrade to Neutral from Underperform | Credit Suisse |
VVR - | VIVA ENERGY REIT | Downgrade to Hold from Add | Morgans |
WOR - | WORLEYPARSONS | Upgrade to Buy from Neutral | UBS |
Overnight Price: $0.61
Macquarie rates AMI as Outperform (1) -
Aurelia Metals' update indicated an increase in capex for the Peak lead-zinc circuit, increased exploration spend and a deferral of the Nymagee pre-feasibility study. Unfavourable results lead the broker to reduce its valuation of Nymagee, while at the same time extending Hera' s mine life by one year as suggested in the update.
Grades at Chronos will be key to reaching production guidance, the broker suggests. Outperform retained, target falls to 85c from $1.00.
Target price is $0.85 Current Price is $0.61 Difference: $0.24
If AMI meets the Macquarie target it will return approximately 39% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of 6.80 cents. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of 13.20 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $78.30
UBS rates ASX as Sell (5) -
UBS observes strong equity markets and volatility in interest rates support stronger second half activity. Average daily cash equity turnover is now up 8.5% while futures volumes are running 14% higher.
Nevertheless, the broker envisages earnings growth will slow to 2.1% in FY20 and 4.7% in FY21. ASX offloaded its stake in IRESS ((IRE)) in February and UBS envisages scope for capital management at the results in August.
Sell rating reiterated, as the dividend yield has compressed to 3%. Target is raised to $62.60 from $58.10.
Target price is $62.60 Current Price is $78.30 Difference: minus $15.7 (current price is over target).
If ASX meets the UBS target it will return approximately minus 20% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $60.66, suggesting downside of -22.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 228.00 cents and EPS of 253.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 254.2, implying annual growth of 5.7%. Current consensus DPS estimate is 228.0, implying a prospective dividend yield of 2.9%. Current consensus EPS estimate suggests the PER is 30.8. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 233.00 cents and EPS of 258.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 263.7, implying annual growth of 3.7%. Current consensus DPS estimate is 235.9, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 29.7. |
Market Sentiment: -0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BVS BRAVURA SOLUTIONS LIMITED
Wealth Management & Investments
More Research Tools In Stock Analysis - click HERE
Overnight Price: $4.91
Macquarie rates BVS as Outperform (1) -
Following Bravura's capital raising, the broker retains Outperform and a $5.50 target. Near term share price weakness has been driven by a recent downgrade from Link Administration ((LNK)), a lack of newsflow re the proposed GBST ((GBT)) takeover and a profit upgrade from GBST, and broader market weakness across Brexit-exposed and tech stocks, the broker notes.
The broker does not see a direct read-through from Link, and while it does see the Brexit/tech issue as having an impact, a defensive earnings stream and high visibility provides some comfort. Post the raising the broker sees focus shift to growth opportunities through M&A and geographical expansion.
Target price is $5.50 Current Price is $4.91 Difference: $0.59
If BVS meets the Macquarie target it will return approximately 12% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 10.50 cents and EPS of 15.00 cents. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 10.90 cents and EPS of 15.50 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.94
Citi rates CLW as Buy (1) -
The company has acquired a $206m portfolio comprising two office assets and one industrial. The acquisition is being funded through a $180m institutional placement.
The company has tightened FY19 guidance to 26.9c per security and introduced FY20 guidance for "no less than 3.75%" growth.
The acquisitions are in line with the stated strategy, with long 10-year lease terms and fixed increases of 3.5% per annum, and increase the exposure to quality tenants.
Citi believes the operating environment remains favourable, maintaining a Buy rating and $5.29 target.
Target price is $5.29 Current Price is $4.94 Difference: $0.35
If CLW meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $4.69, suggesting downside of -5.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 26.90 cents and EPS of 26.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 27.4, implying annual growth of -27.3%. Current consensus DPS estimate is 26.9, implying a prospective dividend yield of 5.4%. Current consensus EPS estimate suggests the PER is 18.0. |
Forecast for FY20:
Citi forecasts a full year FY20 dividend of 28.30 cents and EPS of 28.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 28.7, implying annual growth of 4.7%. Current consensus DPS estimate is 28.2, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 17.2. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates CLW as Underperform (5) -
Charter Hall LW REIT has acquired three assets in Canberra to be partly funded by an institutional placement at $4.74 and an SPP. The REIT has also reset its hedges in order to generate higher earnings per share.
The broker notes hedge resets do increase earnings accretion but destroy value at the same time. The broker also found fresh guidance to be somewhat soft. Underperform retained, target rises to $3.90 from $3.78.
Target price is $3.90 Current Price is $4.94 Difference: minus $1.04 (current price is over target).
If CLW meets the Macquarie target it will return approximately minus 21% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $4.69, suggesting downside of -5.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 26.70 cents and EPS of 28.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 27.4, implying annual growth of -27.3%. Current consensus DPS estimate is 26.9, implying a prospective dividend yield of 5.4%. Current consensus EPS estimate suggests the PER is 18.0. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 28.10 cents and EPS of 29.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 28.7, implying annual growth of 4.7%. Current consensus DPS estimate is 28.2, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 17.2. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.44
Citi rates DCN as Downgrade to Neutral from Buy (3) -
Citi only initiated coverage with a Buy/High Risk rating and a $3 target in May, about three weeks ago, so there will be a number of unhappy faces at the office. Company management has downgraded production guidance in significant manner.
Citi analysts today respond by saying they are "disappointed"; what else are they supposed to say? The recommendation has been pulled back to Neutral/High Risk. Target price falls to (wait for it) $0.60 as the analysts express their concern about the "low Reserve-to-mill reconciliation for gold ounces across the whole operation".
Estimates have been reset, with the analysts explaining what essentially has occurred is that projected output in ounces went down -30% on +41% in costs, while valuation multiples were reduced on top.
Target price is $0.60 Current Price is $0.44 Difference: $0.16
If DCN meets the Citi target it will return approximately 36% (excluding dividends, fees and charges).
Current consensus price target is $2.25, suggesting upside of 411.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 0.00 cents and EPS of 0.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 1.6, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 27.5. |
Forecast for FY20:
Citi forecasts a full year FY20 dividend of 0.00 cents and EPS of 14.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.3, implying annual growth of 1856.3%. Current consensus DPS estimate is 7.5, implying a prospective dividend yield of 17.0%. Current consensus EPS estimate suggests the PER is 1.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $13.39
Deutsche Bank rates DXS as Hold (3) -
Deutsche Bank analysts attended a tour of assets organised by Dexus Property. Their key takeaway from the tour was that leasing conditions in North Sydney remain strong.
Also, the analysts report Dexus management highlighted that 100 Mount Street is now 95% leased, well ahead of time and budget. In addition, management emphasised its trading strategy, which has delivered an average unlevered IRR of 30% over the last 7 years.
Hold. Price target $12.38.
Target price is $12.38 Current Price is $13.39 Difference: minus $1.01 (current price is over target).
If DXS meets the Deutsche Bank target it will return approximately minus 8% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $12.68, suggesting downside of -5.3% (ex-dividends)
Forecast for FY19:
Current consensus EPS estimate is 60.6, implying annual growth of -64.3%. Current consensus DPS estimate is 50.3, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 22.1. |
Forecast for FY20:
Current consensus EPS estimate is 63.5, implying annual growth of 4.8%. Current consensus DPS estimate is 52.9, implying a prospective dividend yield of 4.0%. Current consensus EPS estimate suggests the PER is 21.1. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates DXS as Underperform (5) -
Dexus dragged analysts around North Sydney and St Leonards to highlight positive office market conditions, but the broker remains wary given supply set to come on to the market in the next two-three years.
Despite an incrementally positive update, the broker maintains caution on supply amidst softening demand growth. Underperform and $11.36 target retained.
Target price is $11.36 Current Price is $13.39 Difference: minus $2.03 (current price is over target).
If DXS meets the Macquarie target it will return approximately minus 15% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $12.68, suggesting downside of -5.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 51.00 cents and EPS of 55.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 60.6, implying annual growth of -64.3%. Current consensus DPS estimate is 50.3, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 22.1. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 53.90 cents and EPS of 59.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 63.5, implying annual growth of 4.8%. Current consensus DPS estimate is 52.9, implying a prospective dividend yield of 4.0%. Current consensus EPS estimate suggests the PER is 21.1. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates DXS as Hold (3) -
The company has hosted a tour of its developments in North Sydney and St Leonards. Ord Minnett also updates forecasts to include the acquisition of 80 Collins Street, Melbourne.
Forecasts for adjusted funds from operations have lifted 3-4% over FY20-24. This leads to an increase in the target to $13.50 from $13.00. Hold rating maintained on valuation.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $13.50 Current Price is $13.39 Difference: $0.11
If DXS meets the Ord Minnett target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $12.68, suggesting downside of -5.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 50.00 cents and EPS of 63.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 60.6, implying annual growth of -64.3%. Current consensus DPS estimate is 50.3, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 22.1. |
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 53.00 cents and EPS of 64.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 63.5, implying annual growth of 4.8%. Current consensus DPS estimate is 52.9, implying a prospective dividend yield of 4.0%. Current consensus EPS estimate suggests the PER is 21.1. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GBT GBST HOLDINGS LIMITED
Wealth Management & Investments
More Research Tools In Stock Analysis - click HERE
Overnight Price: $2.65
Morgans rates GBT as Add (1) -
Morgans notes one of the largest retirement income providers in the UK, Canada Life, has chosen the company's Composer wealth management platform.
The broker expects Canada Life will add at least $50m, mostly in licence fees, to revenue over the next decade. Forecasts and valuation are upgraded to incorporate the win.
Add rating maintained. Target is raised to $3.79 from $3.47.
Target price is $3.79 Current Price is $2.65 Difference: $1.14
If GBT meets the Morgans target it will return approximately 43% (excluding dividends, fees and charges).
Current consensus price target is $2.83, suggesting upside of 6.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Morgans forecasts a full year FY19 dividend of 0.00 cents and EPS of 18.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.7, implying annual growth of 92.4%. Current consensus DPS estimate is 0.8, implying a prospective dividend yield of 0.3%. Current consensus EPS estimate suggests the PER is 15.0. |
Forecast for FY20:
Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of 21.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 19.3, implying annual growth of 9.0%. Current consensus DPS estimate is 2.3, implying a prospective dividend yield of 0.9%. Current consensus EPS estimate suggests the PER is 13.7. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
JHX JAMES HARDIE INDUSTRIES N.V.
Building Products & Services
More Research Tools In Stock Analysis - click HERE
Overnight Price: $18.12
Morgan Stanley rates JHX as Overweight (1) -
Morgan Stanley notes FY19 is the fourth year of lower-than-expected claims for asbestos compensation and KPMG expects the peak in claims to approach in FY21.
The broker envisages a declining risk profile for the liability, forecasting payment of 35% of cash flow will cease from FY25. This should allow investors to focus on the core business.
Morgan Stanley reiterates an Overweight rating, $21 target and Cautious industry view.
Target price is $21.00 Current Price is $18.12 Difference: $2.88
If JHX meets the Morgan Stanley target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $21.57, suggesting upside of 19.0% (ex-dividends)
The company's fiscal year ends in March.
Forecast for FY20:
Morgan Stanley forecasts a full year FY20 dividend of 55.43 cents and EPS of 108.08 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 111.8, implying annual growth of N/A. Current consensus DPS estimate is 63.4, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 16.2. |
Forecast for FY21:
Morgan Stanley forecasts a full year FY21 dividend of 62.59 cents and EPS of 125.17 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 125.8, implying annual growth of 12.5%. Current consensus DPS estimate is 73.7, implying a prospective dividend yield of 4.1%. Current consensus EPS estimate suggests the PER is 14.4. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.29
Morgans rates MVF as Add (1) -
Management has guided to a small improvement in FY19 net profit and Morgans assesses this implies more than 15% growth in the second half.
The broker believes guidance is readily achievable as competitive pressures have moderated. Modest upgrades are made to FY20 and FY21 estimates.
Add rating maintained. Target is raised to $1.25 from $1.13.
Target price is $1.25 Current Price is $1.29 Difference: minus $0.04 (current price is over target).
If MVF meets the Morgans target it will return approximately minus 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY19:
Morgans forecasts a full year FY19 dividend of 6.00 cents and EPS of 9.00 cents. |
Forecast for FY20:
Morgans forecasts a full year FY20 dividend of 6.10 cents and EPS of 9.00 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.61
Macquarie rates NHC as Neutral (3) -
New Hope's quarterly production report featured a mix of a beat in NSW and a miss in Queensland. A slightly weaker yield in NSW tapers the brokers expectations for Bengalla, and New Hope's debt facility will be drawn down further to pay for the remaining 10% stake.
The broker had always remained cautious on the New Acland stage 3 expansion, and outside media reports have suggested approvals will not be granted before the company is forced to begin a ramp-down. The broker sees the potential for considerable downgrades to consensus estimates. Neutral retained, target falls to $2.50 from $3.00.
Target price is $2.50 Current Price is $2.61 Difference: minus $0.11 (current price is over target).
If NHC meets the Macquarie target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $3.27, suggesting upside of 25.2% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 17.70 cents and EPS of 43.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 44.4, implying annual growth of 146.7%. Current consensus DPS estimate is 15.9, implying a prospective dividend yield of 6.1%. Current consensus EPS estimate suggests the PER is 5.9. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 13.50 cents and EPS of 26.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 30.4, implying annual growth of -31.5%. Current consensus DPS estimate is 13.5, implying a prospective dividend yield of 5.2%. Current consensus EPS estimate suggests the PER is 8.6. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates STO as Upgrade to Neutral from Underperform (3) -
Credit Suisse believes Santos is less exposed than Oil Search ((OSH)) to risk around LNG price reviews. Santos has the strength in its balance sheet to mitigate the risk.
The broker models a -0.5% slope drop at PNG LNG in its base case or a -5c/share impact. The Darwin LNG price review presents a negligible impact, given limited remaining life but could set a precedent, the broker suggests.
Rating is upgraded to Neutral from Underperform. Target is reduced to $6.35 from $6.40.
Target price is $6.35 Current Price is $6.73 Difference: minus $0.38 (current price is over target).
If STO meets the Credit Suisse target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $7.03, suggesting upside of 4.5% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY19:
Credit Suisse forecasts a full year FY19 dividend of 12.24 cents and EPS of 69.72 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.0, implying annual growth of N/A. Current consensus DPS estimate is 14.6, implying a prospective dividend yield of 2.2%. Current consensus EPS estimate suggests the PER is 11.4. |
Forecast for FY20:
Credit Suisse forecasts a full year FY20 dividend of 9.65 cents and EPS of 75.44 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 61.3, implying annual growth of 3.9%. Current consensus DPS estimate is 13.5, implying a prospective dividend yield of 2.0%. Current consensus EPS estimate suggests the PER is 11.0. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.74
Macquarie rates VOC as Neutral (3) -
EQT has pulled its $5.25 indicative offer for Vocus after a brief period of due diligence, without offering a reason as to why.
The broker has dropped its target price to $4.10 from $4.70 in response and retains Neutral for the moment until volatility subsides in the share price, pending reassessment.
Target price is $4.10 Current Price is $3.74 Difference: $0.36
If VOC meets the Macquarie target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $4.05, suggesting upside of 8.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of 17.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 15.2, implying annual growth of 54.9%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 24.6. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of 20.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.7, implying annual growth of 9.9%. Current consensus DPS estimate is 0.5, implying a prospective dividend yield of 0.1%. Current consensus EPS estimate suggests the PER is 22.4. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.58
Morgans rates VVR as Downgrade to Hold from Add (3) -
Following appreciation in the stock, over the past year it has risen 35.7%, Morgans downgrades to Hold from Add. The base earnings year is moved to FY20 and, as a result, the target increases to $2.61 from $2.52.
The broker asserts there is a sustainable distribution yield and the stock is attractive for income investors. One third of the portfolio is independently revalued every three years.
Target price is $2.61 Current Price is $2.58 Difference: $0.03
If VVR meets the Morgans target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $2.55, suggesting downside of -1.2% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY19:
Morgans forecasts a full year FY19 dividend of 14.50 cents and EPS of 14.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 14.8, implying annual growth of -30.6%. Current consensus DPS estimate is 14.8, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 17.4. |
Forecast for FY20:
Morgans forecasts a full year FY20 dividend of 15.30 cents and EPS of 15.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 15.2, implying annual growth of 2.7%. Current consensus DPS estimate is 15.2, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 17.0. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
WOR WORLEYPARSONS LIMITED
Energy Sector Contracting
More Research Tools In Stock Analysis - click HERE
Overnight Price: $13.11
Citi rates WOR as Buy (1) -
Citi notes integration of Jacobs ECR is continuing to track ahead of expectations. The broker envisages upside risk from the acquisition from both the revenue and margin perspectives. Cost synergy targets have been upgraded by 15%, with 60-70% of the synergies to be delivered in the first 12 months.
The broker believes the company will continue to leverage global delivery capabilities in India and China. Buy rating maintained. Target is reduced to $18.10 from $18.85. This reflects lower medium-term earnings and higher capital expenditure for additional investment in the modernisation of systems.
Target price is $18.10 Current Price is $13.11 Difference: $4.99
If WOR meets the Citi target it will return approximately 38% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Citi forecasts a full year FY19 dividend of 33.50 cents and EPS of 63.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Citi forecasts a full year FY20 dividend of 62.00 cents and EPS of 102.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates WOR as Outperform (1) -
The company's investor briefing has shown how the combined business is positioning to capture more work as Jacobs ECR is integrated. Credit Suisse remains comfortable that, pending a smooth integration, leverage to the controlled cost base and new scale will provide unique exposure to the global energy mix.
Cost synergies have been lifted to $150m, with the majority expected to be achieved in the first 12 months, a target the broker suspects could prove conservative. Credit Suisse maintains an Outperform rating and $18.20 target.
Target price is $18.20 Current Price is $13.11 Difference: $5.09
If WOR meets the Credit Suisse target it will return approximately 39% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Credit Suisse forecasts a full year FY19 dividend of 31.67 cents and EPS of 50.92 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Credit Suisse forecasts a full year FY20 dividend of 54.78 cents and EPS of 91.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Deutsche Bank rates WOR as Buy (1) -
Deutsche Bank analysts have kept their Buy rating and lifted the price target to $20.60, effectively nullifying the target decrease put in place in February. It appears the investor day organised by the company broadly disappointed.
Deutsche Bank reports management indicated near-term activity remains somewhat muted with backlog stable between Dec-18 and Mar-19. Also, geopolitical risks are dampening expectations for project awards in the short term.
The analysts had hoped for better news, but at this point see the disappointment largely as a timing issue.
Target price is $20.60 Current Price is $13.11 Difference: $7.49
If WOR meets the Deutsche Bank target it will return approximately 57% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
Forecast for FY19:
Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates WOR as Outperform (1) -
WorleyParsons has upgraded its cost-out expectations from the Jacob's ECR acquisition to $150m from $130m over two years, which the broker sees as a good signal after only five weeks of ownership.
Moreover, management highlighted a margin opportunity via shared services and an integrated delivery centre in low-cost India, which is not included in the cost-out number.
The broker continues to see the stock as undervalued and expects a re-rating. Outperform retained, target rises to $21.48 from $21.38.
Target price is $21.48 Current Price is $13.11 Difference: $8.37
If WOR meets the Macquarie target it will return approximately 64% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 27.50 cents and EPS of 66.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 38.10 cents and EPS of 110.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates WOR as Equal-weight (3) -
Morgan Stanley believes the risks are growing for a deflationary period in oil & gas driven by the resilience of shale production in North America, which means OPEC is ceding market share and this is rarely good for oil prices over the longer term.
The main challenge for WorleyParsons' upstream business is that it it has very little exposure to shale. The broker observes some frustration by management at the investor briefing regarding the lower share price yet believes the correlation to oil prices is unlikely to disappear quickly.
Some valuation upside is envisaged from the current share price and the broker expects solid earnings growth over time. Equal-weight rating. Target is $16.00. Industry view is In-Line.
Target price is $16.00 Current Price is $13.11 Difference: $2.89
If WOR meets the Morgan Stanley target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Morgan Stanley forecasts a full year FY19 dividend of 28.60 cents and EPS of 61.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Morgan Stanley forecasts a full year FY20 dividend of 45.75 cents and EPS of 92.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates WOR as Buy (1) -
Ord Minnett found nothing to change its view after the company hosted an upbeat investor briefing. The focus was on the opportunities presented by the recent acquisition of Jacobs ECR.
Near-term growth appears a little more anaemic, amid caution regarding the current macroeconomic environment.
The broker is pleased with indications that further M&A is on hold, at least until the Jacobs acquisition is fully integrated. Buy rating and $18.50 target maintained.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $18.50 Current Price is $13.11 Difference: $5.39
If WOR meets the Ord Minnett target it will return approximately 41% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 29.00 cents and EPS of 54.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 53.00 cents and EPS of 90.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates WOR as Upgrade to Buy from Neutral (1) -
UBS upgrades to Buy from Neutral as the stock appears more attractive on a valuation basis after a -15% reduction in the share price in the last quarter. The broker expects earnings (EBIT) growth of 96% in FY20 and 13% in FY21, supported by the acquisition of Jacobs ECR.
UBS notes an upbeat assessment of end-market capital expenditure from the investor briefing, with potential revenue synergies emerging from the cross-selling of the Worley/Jacobs ECR service platforms. Target is reduced to $16.00 from $17.10.
Target price is $16.00 Current Price is $13.11 Difference: $2.89
If WOR meets the UBS target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $18.41, suggesting upside of 40.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 27.00 cents and EPS of 61.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 59.5, implying annual growth of 155.4%. Current consensus DPS estimate is 29.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 22.0. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 44.00 cents and EPS of 93.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 96.5, implying annual growth of 62.2%. Current consensus DPS estimate is 49.6, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
Company | Broker | New Target | Prev Target | Change | |
AMI | AURELIA METALS | Macquarie | 0.85 | 1.00 | -15.00% |
ASX | ASX | UBS | 62.60 | 58.10 | 7.75% |
CLW | CHARTER HALL LONG WALE REIT | Macquarie | 3.90 | 3.78 | 3.17% |
DCN | DACIAN GOLD | Citi | 0.60 | 3.00 | -80.00% |
DXS | DEXUS PROPERTY | Deutsche Bank | 12.38 | 11.63 | 6.45% |
Ord Minnett | 13.50 | 13.00 | 3.85% | ||
GBT | GBST HOLDINGS | Morgans | 3.79 | 3.47 | 9.22% |
MVF | MONASH IVF | Morgans | 1.25 | 1.13 | 10.62% |
NHC | NEW HOPE CORP | Macquarie | 2.50 | 3.00 | -16.67% |
STO | SANTOS | Credit Suisse | 6.35 | 6.40 | -0.78% |
VOC | VOCUS GROUP | Macquarie | 4.10 | 4.70 | -12.77% |
VVR | VIVA ENERGY REIT | Morgans | 2.61 | 2.52 | 3.57% |
WOR | WORLEYPARSONS | Citi | 18.10 | 18.85 | -3.98% |
Deutsche Bank | 20.60 | 19.95 | 3.26% | ||
Macquarie | 21.48 | 21.38 | 0.47% | ||
UBS | 16.00 | 17.10 | -6.43% |
Summaries
AMI | AURELIA METALS | Outperform - Macquarie | Overnight Price $0.61 |
ASX | ASX | Sell - UBS | Overnight Price $78.30 |
BVS | BRAVURA SOLUTIONS | Outperform - Macquarie | Overnight Price $4.91 |
CLW | CHARTER HALL LONG WALE REIT | Buy - Citi | Overnight Price $4.94 |
Underperform - Macquarie | Overnight Price $4.94 | ||
DCN | DACIAN GOLD | Downgrade to Neutral from Buy - Citi | Overnight Price $0.44 |
DXS | DEXUS PROPERTY | Hold - Deutsche Bank | Overnight Price $13.39 |
Underperform - Macquarie | Overnight Price $13.39 | ||
Hold - Ord Minnett | Overnight Price $13.39 | ||
GBT | GBST HOLDINGS | Add - Morgans | Overnight Price $2.65 |
JHX | JAMES HARDIE | Overweight - Morgan Stanley | Overnight Price $18.12 |
MVF | MONASH IVF | Add - Morgans | Overnight Price $1.29 |
NHC | NEW HOPE CORP | Neutral - Macquarie | Overnight Price $2.61 |
STO | SANTOS | Upgrade to Neutral from Underperform - Credit Suisse | Overnight Price $6.73 |
VOC | VOCUS GROUP | Neutral - Macquarie | Overnight Price $3.74 |
VVR | VIVA ENERGY REIT | Downgrade to Hold from Add - Morgans | Overnight Price $2.58 |
WOR | WORLEYPARSONS | Buy - Citi | Overnight Price $13.11 |
Outperform - Credit Suisse | Overnight Price $13.11 | ||
Buy - Deutsche Bank | Overnight Price $13.11 | ||
Outperform - Macquarie | Overnight Price $13.11 | ||
Equal-weight - Morgan Stanley | Overnight Price $13.11 | ||
Buy - Ord Minnett | Overnight Price $13.11 | ||
Upgrade to Buy from Neutral - UBS | Overnight Price $13.11 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 12 |
3. Hold | 8 |
5. Sell | 3 |
Thursday 06 June 2019
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.